US Stock MarketDetailed Quotes

MRK Merck & Co

Watchlist

99.870
+0.420+0.42%

Close Dec 26 16:00 ET

99.750
-0.120-0.12%

Post 20:01 ET

252.63BMarket Cap20.89P/E (TTM)

Merck & Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Merck & Co Q3 2024 Earnings Date

Currency：USDOct 31, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	16.51B	16.66B	+143.16M
Beat Est.	+3.46%	+4.35%	+0.87%
EPS	1.43	1.24	-0.19
Miss Est.	-23.03%	-33.33%	-13.39%

Analyst Rating

Strong Buy

Dec 20, 2024

Merck & Co Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Apr 24, 2025	2025/Q1	-- / 16.587B	--
--	2024/Q4	-- / 15.475B	--
Oct 31, 2024	2024/Q3	16.657B / 16.514B	--
Jul 30, 2024	2024/Q2	16.112B / 15.844B	--
Apr 25, 2024	2024/Q1	15.775B / 15.204B	--

DatePeriodRevenue/EstimateEarnings Call

Apr 24, 20252025/Q1-- / 16.587B--

--2024/Q4-- / 15.475B--

Oct 31, 20242024/Q316.657B / 16.514B--

Jul 30, 20242024/Q216.112B / 15.844B--

Apr 25, 20242024/Q115.775B / 15.204B--

Unlock Free Earnings Estimates

Open Account

Merck & Co Earnings Reports

Merck & Co | 10-Q: Q3 2024 Earnings Report

Nov 6 16:08 ET

Merck & Co | 8-K: Merck Announces Third-Quarter 2024 Financial Results

Oct 31 06:46 ET

Merck & Co | 10-Q: Q2 2024 Earnings Report

Aug 5 16:07 ET

Merck & Co | 8-K: Merck Announces Second-Quarter 2024 Financial Results

Jul 30 06:46 ET

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 20, 2024

Strong Buy

Buy
76.00%
Hold
24.00%
Sell
0.00%

Price Target

No Data